RXANTE, LLC – Trademark Portfolio
Entity Type: 16
RXANTE, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include VFA, RXANTE, RXEFFECT, PREDICT.DECIDE.LEARN., and THE FUTURE OF PATIENT ADHERENCE. The owner is based in Arlington, VA.
901 N. Glebe Rd, Suite 850
Arlington, VA 22203
Showing of trademarks Trademarks
Trademark Classifications
RXANTE, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does RXANTE, LLC have?
RXANTE, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.
What trademark classes does RXANTE, LLC file in?
RXANTE, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are RXANTE, LLC's most well-known trademarks?
RXANTE, LLC's registered trademark portfolio includes well-known marks such as VFA, RXANTE, RXEFFECT, PREDICT.DECIDE.LEARN., and THE FUTURE OF PATIENT ADHERENCE. These are among 6 currently registered trademarks in the portfolio.
What is RXANTE, LLC's trademark registration success rate?
RXANTE, LLC has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.